Precision Neuro Stock

Specializes in the development of minimally invasive brain–computer interface (BCI) technology.

Price Per Share $7.20 +198.97%
Updated May 29, 2026

Precision Neuro Share Price

You can scroll over the chart's area to move in time and tap to see a specific date.

6 Months 12 Months 24 Months

Highest Bid

$ 260.80

Lowest Offer

$ 188.50

Last Trade

$ 234.00

Live Orders

1,298

View Precision Neuro Market

Buy

Buy Precision Neuro shares

Sign up to view historical trading trends and place an offer.

Sell

Sell Precision Neuro shares

Understand share pricing, list anonymously, and benefit from transparent fees.

Overview

Precision Neuroscience specializes in the development of minimally invasive brain–computer interface (BCI) technology.

Sector

Healthcare & Life Sciences

Founded

2020

Headquarters

New York, NY

Precision Neuro Funding

Precision Neuro Funding History

Sign up to gain insights into Precision Neuro funding history, including the funding round, time period, and amount raised.

Financing Round Date Amount Price per share Valuation
Round Date Amount PPS Valuation
Series C Dec 16, 2024 102M
XXXXX
XXXXX
Series B Feb 01, 2023 7M
XXXXX
XXXXX
Series B Dec 05, 2022 34M
XXXXX
XXXXX
Series A May 25, 2021 12M
XXXXX
XXXXX

Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market

Buy

Buy Precision Neuro shares

Sign up to view historical trading trends and place an offer.

Sell

Sell Precision Neuro shares

Understand share pricing, list anonymously, and benefit from transparent fees.

Precision Neuro Management Team

Precision Neuro people and management

  • Board Member
    Jason Chen
  • Board Member
    Ravi Mehta
  • Board Member
    Eric Attias
  • Board Member
    Howard Morgan
  • CFO
    Mike Kaswan
  • Chief Business Officer
    John Woock
  • Chief Commercial and Clinical Officer
    Jayme Strauss
  • Co-Founder, CEO
    Michael Mager
  • Co-Founder, Chief Science Officer, Board Member
    Benjamin Rapoport
  • Co-Founder, VP of Engineering and Microfabrication
    Mark Hettick
  • CTO
    Brian Otis
  • President, Chief Product Officer, Board Member
    Craig Mermel

Investors

Major Precision Neuro investors

  • Draper Fisher Jurvetson (DFJ)

  • Duquesne Family Office

  • Mubadala Capital

  • Alumni Ventures

  • ForgePoint Capital

  • re.Mind Capital

  • General Equity Holdings

  • Steadview Capital

  • B Capital Group

Precision Neuro Valuations & Financials

Gain Insights Into Precision Neuro Stock Valuation & Share Prices

View real-time NPM data on Precision Neuro stock including daily Precision Neuro stock price estimates, valuation history, and historical share price information. Access Precision Neuro financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Precision Neuro pricing across six independent market signals. Looking for private company due diligence data sources on Precision Neuro? Get in touch to learn more.

Similar Companies

Explore companies

like Precision Neuro

  • Curology-Logo

    Curology

    Healthcare & Life Sciences

    Offers personalized prescription skin care medications delivered directly to you.

  • Cedar Inc-Logo

    Cedar

    Healthcare & Life Sciences

    The tech platform uses modern intelligence to improve healthcare financial experiences for everyone.

  • Weareresilience-Logo

    Resilience

    Healthcare & Life Sciences

    Operates as technology-focused biomanufacturing company dedicated to broadening access to complex medicines.

  • Cerebral

    Healthcare & Life Sciences

    Telemedicine mental health startup, providing evidence-based therapeutic techniques and medication management.

  • Devoted Health

    Healthcare & Life Sciences

    Provides Medicare Advantage plans to improve older Americans' well-being with comprehensive and family-oriented care.

  • Roman Health Ventures-Logo

    Ro

    Healthcare & Life Sciences

    Healthcare technology for a patient-centric healthcare system.

  • OpenEvidence

    Healthcare & Life Sciences

    Empowers clinicians who seek evidence‑based insights by delivering AI‑summarized medical research at the point of care.

  • Somatus-Logo

    Somatus

    Healthcare & Life Sciences

    Integrated care for patients with or at risk of developing kidney disease.

  • Lyra Healthcare-Logo

    Lyra

    Healthcare & Life Sciences

    Digital health startup using technology to connect companies and employees to mental health providers.

FAQ

Questions?

We have answers

Buy Precision Neuro Stock

Precision Neuro stock does not trade on public stock exchanges. Precision Neuro stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Precision Neuro stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.

Learn more about the secondary market for private company shares on the investors page.

Sell Precision Neuro Stock

Precision Neuro Stock does not trade on public stock exchanges. In order to sell Precision Neuro shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.

Learn more about NPM services for selling privately held stock on the Employee Shareholders page.

Read more about how to sell private company stock on the private secondary market:

 

Precision Neuro Stock Price

Nasdaq Private Market estimates that Precision Neuro price per share was $7.2 as of May 29, 2026. This Precision Neuro share value estimate (known as the NPM price) is based on market activity, publicly-sourced valuation data, and other proprietary information. With NPM Data and Intelligence premium for investors, you can get visibility into the Precision Neuro share price today and the factors driving Precision Neuro valuation estimates. Learn more about premium data here.

Read more about private company stock prices: Understanding the Bid-Ask Spread: How Buyers and Sellers Match on Price

Precision Neuro Stock Ticker Symbol

There is no ticker symbol for Precision Neuro stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.

Criteria to Sell Precision Neuro Stock

Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Precision Neuro stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.

Learn more about selling privately held stock on the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

 

Criteria to Buy or Invest in Precision Neuro Stock

Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Precision Neuro stock, you need to be an accredited entity or institutional investor.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

Precision Neuro Stock Settlement

Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

Precision Neuro IPO

Precision Neuro is a private company and has not had an IPO. There is currently no Precision Neuro IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Precision Neuro IPO.

Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.